Euretos offers a bio-informatics knowledge platform that connects over 7 million known phenotypic, genetic, proteomic, metabolic and chemical concepts. Content is derived from scientific literature and databases with full references to sources. The platform provides the similarity, specificity and interaction strength of all its connections, even predicting their likelihood if not existing. The company focuses on two markets. In therapy development it enables the identification and validation of novel targets and biomarkers. In clinical diagnostics it enables effective diagnosis of suspected gene variant - disease associations not yet described in literature.
Category Digital Health Company
Buyer Pharma
Setting Other
User Pharma
Purpose Clinical Research